Neo Ivy Capital Management’s Humana HUM Stock Holding History

Neo Ivy Capital Management’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$814K	Buy	4,694 +3,719	+381%	+$762K	0.21%	157
2025 Q4	$250K	Buy	+975	New	+$256K	0.04%	252
2023 Q4	$952K	Buy	+2,079	New	+$1.02M	2.13%	8
2023 Q3	–	Sell	-7,737	Closed	-$3.46M	–	381
2023 Q2	$3.46M	Buy	+7,737	New	+$3.89M	1.82%	1
2022 Q3	–	Sell	-148	Closed	-$69K	–	453
2022 Q2	$69K	Sell	148 -2,458	-94%	-$1.09M	0.18%	194
2022 Q1	$1.13M	Buy	2,606 +1,649	+172%	+$690K	1.02%	3
2021 Q4	$444K	Buy	+957	New	+$423K	0.64%	32

Other funds holding HUM

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Neo Ivy Capital Management's HUM Position: Q1 2026 in Review

Neo Ivy Capital Management increased its Humana (HUM) stake by 381% in Q1 2026, buying an estimated $762K and bringing the position to 4,694 shares worth $814K. The position accounts for 0.21% of the portfolio, ranked #157.

Neo Ivy Capital Management first reported a position in HUM in Q4 2021 and has held it in 7 quarters since. The position peaked at $3.46M in Q2 2023. 781 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

Neo Ivy Capital Management held 4,694 shares of Humana worth $814K as of Q1 2026.
Neo Ivy Capital Management bought 3,719 Humana shares in Q1 2026, an estimated $762K.
Humana made up 0.21% of Neo Ivy Capital Management's portfolio in Q1 2026, its #157 holding.
Neo Ivy Capital Management first reported a position in Humana in Q4 2021 and has held it in 7 quarters since.
Neo Ivy Capital Management's Humana position peaked at $3.46M in Q2 2023.
781 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.